A major clinical trial has delivered an unexpected twist in the search for ways to fight COVID-19 and its lingering effects. Researchers at Mass General Brigham found that taking high doses of vitamin ...

Vitamin D3 did not affect COVID-19-related health care outcomes at 4 weeks but may have contributed to a reduction in long COVID risk.

In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.

In a large, randomized trial, researchers at Mass General Brigham found that high-dose vitamin D3 did not reduce COVID-19 ...

High-dose Vitamin D doesn't reduce acute COVID severity but shows a promising signal for reducing Long COVID and brain fog.

New study reveals vitamin D supplements may reduce long COVID risk by 4%. Promising results for symptoms like fatigue and ...

A randomized trial found that high-dose vitamin D3 did not reduce COVID-19 severity, healthcare visits, or infection rates among household contacts. However, participants who adhered to supplements ...

Vitamin D didn’t blunt COVID’s initial impact—but it may hold a surprising clue in the fight against long COVID.

India, March 16 -- Researchers at Mass General Brigham conducted one of the largest randomized trials to examine whether vitamin D supplementation could influence COVID-19 outcomes.

Routine data from laboratories reveal a decline in vitamin D levels during the Covid-19 pandemic, especially in older women and urban dwellers. The Covid-19 pandemic had effects on human health well ...